Dabigo 75 mg
| SKU | 2637 |
|---|---|
| Generic For | Pradaxa |
| Manufacturer | MSN Laboratories Ltd |
| Active Ingredient | Dabigatran Etexilate |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Capsule/s | US$ 0.62 | US$ 18.60 | |||
|
|||||
| 60 Capsule/s | US$ 0.56 | US$ 33.4810%US$ 37.20 | |||
|
|||||
| 90 Capsule/s | US$ 0.43 | US$ 39.0030%US$ 55.80 | |||
|
|||||
Dabigo 75 mg (Dabigatran Etexilate) – Affordable Pradaxa Alternative
Dabigo 75mg contains the active component of Dabigatran, a blood-thinning medicine that lowers the risk of blood clots forming in the body. It is a prescription medicine for:
- Lowering the chance of stroke and blood clots in adults with the medical condition of atrial fibrillation (irregular heart rhythm). In the case of atrial fibrillation, part of the heart does not beat properly. The condition may lead to the formation of blood clots and increases the risk of developing a stroke.
- Treating blood clots in the veins of lungs and legs after a patient receives a medicine to treat blood clots for up to 5 to 10 days.
- Reducing the chance of blood clots from developing again in the veins of your lungs and legs after patients have received blood clot treatment.
- Preventing blood clots in lungs and veins after an individual has just undergone hip replacement surgery.
Dabigo can also be prescribed to treat blood clots in pediatrics 8 years to under 18 years of age who have medicine via intravenous/Intramuscular route to treat their blood clots for at least five days. It lowers the risk of blood clots developing again in children aged 8 to under 18 years who have received blood clot treatment.
Precaution with Dabigatran
The use of Dabigo 75 mg is contraindicated in the following conditions:
- Known hypersensitivity to Dabigatran or any other ingredients in the formulation.
- Severe kidney disease
- Active bleeding, including gastrointestinal bleeding.
- Lesions at risk of clinically significant bleeding, e.g., extensive cerebral infarction within the last six months, active peptic ulcer disease with recent bleeding, active peptic ulcer with recent bleeding.
- Combination with oral ketoconazole
- Prosthetic heart valve requiring anticoagulation
- Nursing women
The effects of Dabigo on pregnancy and the unborn child are not known. The medicine should not be used during pregnancy unless recommended by a doctor, as it is not safe to do so. Women of reproductive potential should avoid becoming pregnant while taking the medicine. Furthermore, it is best to avoid breastfeeding while taking a Dabigatran formulation. Dabigatran has no known effects on the ability to drive or use machines. It is still unknown if the blood-thinning medicine is safe and effective in kids with atrial fibrillation not caused by heart valve conditions or in children who have had hip replacement surgery.
Side effects of Dabigatran
Allergic reactions: Some adults receiving Dabigo capsules have been reported to develop symptoms of an allergic reaction. Consult your healthcare professional immediately in the event of an allergic reaction. Common symptoms include rash, itching, and hives. Seek immediate medical advice if serious allergic symptoms with the use of a Dabigatran capsule occur, and these may include:
- Swelling of your face or tongue
- Feeling dizzy or faint
- Chest pain or chest tightness
- Trouble breathing or wheezing
Common side effects of the medicine in adults and children include upset stomach, indigestion, burning, and stomach pain or discomfort. Children usually may experience nausea, vomiting, and diarrhea.
How to use Dabigatran?
Dabigo is for oral use. It is available in capsule form and can be taken before or after meals. The tablet should be swallowed whole with an adequate amount of water to facilitate delivery to the stomach. Patients are instructed not to open the capsule, as this increases the likelihood of bleeding. The doctor recommends Pradaxa-coated granules as the best option for children under eight years who are prescribed Dabigatran.
Dabigo 75 mg should not be discontinued without consulting a doctor. Sudden discontinuation may increase your risk of developing a stroke or forming blood clots. Patients should be instructed to talk to their contact healthcare provider if they develop stomach-related symptoms such as dyspepsia. Let your doctor decide how long a medication needs to be taken.
In adults, Dabigo capsules are usually recommended two times a day. The medicines may need to be taken once daily for treatment after hip surgery. It is recommended that the capsule be swallowed with a glass of water. If the child cannot swallow the capsule, avoid emptying the pellets from the capsules and seek immediate doctor’s advice.
In children: It is recommended that they take Dabigo capsules two times a day. It is usually advised to take one dose in the evening, approximately twelve hours before bedtime.
The medication can be consumed before or after consuming food. Stomach problems can be relieved if taken with food.
Treatment with Dabigo 75 mg in patients with severe kidney disease is contraindicated. Those with moderate renal insufficiency can be given a lower dose, as dose reduction is recommended in such patients. Doctors may recommend dose reduction for older patients aged 75 years and above.
What is Dabigatran Etexilate and what condition does it treat?
Dabigatran Etexilate is an oral anticoagulant medication, often referred to as a blood thinner, used to prevent dangerous blood clots from forming in the body. Dabigo 75 mg contains this active ingredient and is prescribed primarily to reduce stroke risk in patients with atrial fibrillation not caused by heart valve problems. This medication also treats and prevents deep vein thrombosis (DVT) and pulmonary embolism (PE). As a direct thrombin inhibitor, it works differently from traditional anticoagulants like warfarin, offering patients a modern approach to clot prevention without requiring routine blood monitoring in most cases.
How does Dabigatran Etexilate work in the body?
Dabigatran Etexilate functions as a direct thrombin inhibitor, blocking the action of thrombin, a key enzyme responsible for blood clot formation. When you take Dabigo 75 mg, the medication is absorbed and converted into its active form, which then binds to thrombin and prevents it from converting fibrinogen into fibrin strands that form clots. Unlike older anticoagulants such as warfarin that work indirectly through vitamin K pathways, this blood thinner provides targeted action with more predictable effects. This mechanism makes it effective for stroke prevention in atrial fibrillation patients and helps prevent venous thromboembolism.
How long does Dabigo 75 mg take to work?
Dabigo 75 mg reaches peak blood concentration approximately two hours after oral administration, meaning the anticoagulant effect of Dabigatran Etexilate begins relatively quickly. Maximum blood-thinning activity typically occurs within two to three hours of taking your dose. However, achieving stable therapeutic levels for optimal stroke prevention and clot protection usually requires several days of consistent dosing. The medication's effects diminish fairly rapidly once discontinued, with anticoagulant activity substantially reduced within 12 to 24 hours. This relatively fast onset and offset make this direct thrombin inhibitor a convenient option for many patients requiring anticoagulation therapy.
When and how should I take Dabigo 75 mg?
Take Dabigo 75 mg exactly as your healthcare provider prescribes, typically twice daily at approximately the same times each morning and evening. Swallow the capsule whole with water—do not open, crush, or chew it, as this can increase bleeding risk by releasing too much Dabigatran Etexilate at once. You may take this anticoagulant with or without food. Consistency matters significantly for maintaining stable blood-thinning effects and stroke prevention. If you miss a dose and it's more than six hours until your next scheduled dose, take it immediately; otherwise, skip it and resume your regular schedule. Never double doses of this blood thinner.
Is Dabigo 75 mg safe for long-term use?
Dabigo 75 mg containing Dabigatran Etexilate is designed for long-term use in chronic conditions like atrial fibrillation where ongoing stroke prevention is essential. Clinical studies spanning several years have demonstrated this anticoagulant's safety profile for extended therapy when properly monitored. Long-term users benefit from not requiring the frequent blood tests that older blood thinners demand. However, your healthcare provider will periodically assess kidney function since this medication is eliminated through the kidneys, and renal impairment affects how your body processes the drug. Age, bleeding history, and concurrent medications influence individual safety, making regular medical follow-up important throughout treatment.
Can I take Dabigo 75 mg with other medicines?
Dabigatran Etexilate in Dabigo 75 mg can interact with several medication classes, particularly other anticoagulants, antiplatelet drugs like aspirin or clopidogrel, and NSAIDs such as ibuprofen, all of which increase bleeding risk. Certain medications affecting drug transporters, including rifampin and some antifungals, can alter this blood thinner's effectiveness. Proton pump inhibitors may slightly reduce absorption. Always inform prescribers and pharmacists about all medications, supplements, and herbal products you use. Your doctor will evaluate potential interactions and may adjust doses or recommend alternatives. PremiumRxDrugs provides medication interaction screening during the prescription review process for your safety.
How does Dabigo 75 mg compare to similar medicines in its class?
Dabigo 75 mg belongs to the direct oral anticoagulant (DOAC) class, which includes alternatives like rivaroxaban, apixaban, and edoxaban. Unlike warfarin requiring regular INR monitoring, Dabigatran Etexilate offers predictable anticoagulation without routine blood tests. The 75 mg strength is specifically indicated for patients with moderate kidney impairment or those at higher bleeding risk. Compared to other DOACs that inhibit Factor Xa, this medication uniquely targets thrombin directly. Dabigo typically requires twice-daily dosing whereas some alternatives offer once-daily convenience. Effectiveness for stroke prevention in atrial fibrillation is comparable across DOACs, though individual patient factors guide optimal selection.
Is the generic Dabigatran Etexilate as effective as branded versions?
Generic Dabigatran Etexilate, including Dabigo 75 mg, contains the identical active pharmaceutical ingredient as the original branded product and must meet stringent regulatory standards proving bioequivalence. This means the generic anticoagulant is absorbed and works in your body at the same rate and extent as the brand-name version, delivering equivalent stroke prevention and clot treatment benefits. Regulatory agencies worldwide require generic blood thinners to demonstrate therapeutic equivalence through rigorous testing. Patients choosing generics through licensed pharmacies like PremiumRxDrugs receive authentic, manufacturer-sourced medications at more competitive pricing while maintaining the same clinical effectiveness and safety profile.
Why do patients choose PremiumRxDrugs for Dabigo 75 mg?
Patients select PremiumRxDrugs for Dabigo 75 mg because the pharmacy combines affordability with reliability for long-term anticoagulation therapy. As a licensed facility trusted for more than ten years, we offer manufacturer-sourced Dabigatran Etexilate at competitive prices—important for medications taken indefinitely. The convenient reorder system simplifies ongoing prescription management for this twice-daily blood thinner. Discreet worldwide shipping with free delivery options reaches patients in the USA, UK, Australia, Canada, and beyond. The pharmacy's licensing ensures proper prescription verification and access to professional guidance, while authentic-only sourcing eliminates counterfeit concerns. For chronic conditions requiring consistent anticoagulation and stroke prevention, this combination proves valuable.
What are the common side effects of Dabigatran Etexilate?
Dabigatran Etexilate commonly causes bleeding-related effects since it's an anticoagulant designed to prevent clotting. Users may experience easy bruising, minor bleeding from gums when brushing, or nosebleeds. Gastrointestinal symptoms including stomach discomfort, indigestion, nausea, or diarrhea affect some patients, particularly when starting this blood thinner. Some people notice bleeding that takes longer to stop from minor cuts. Serious but less common effects include unusual bleeding, blood in urine or stools appearing red or black, or severe headaches potentially indicating internal bleeding. The 75 mg dosage is specifically formulated for patients requiring reduced exposure, which may minimize certain adverse effects compared to standard-strength formulations.
Who should avoid taking Dabigatran Etexilate?
Dabigatran Etexilate is contraindicated for individuals with active pathological bleeding, severe kidney failure, or mechanical heart valves. Patients with significantly impaired renal function cannot adequately eliminate this anticoagulant, leading to dangerous accumulation. Those with artificial heart valves require different anticoagulation approaches as this medication hasn't proven effective for that indication. People with bleeding disorders, recent major surgery, or conditions increasing bleeding risk need careful evaluation before starting this blood thinner. Pregnant or breastfeeding women should avoid it due to potential fetal harm. Anyone allergic to the medication or taking certain interacting drugs may require alternatives for stroke prevention and clot treatment.
Login
Sign Up
Login
Sign Up